The Trump administration's "Operation Warp Speed" is led by Dr. Moncef Slaoui, a former board member of Moderna, raising concerns about pharmaceutical industry influence. Simultaneously, questions arise regarding the accuracy of COVID-19 death counts, as hospitals receive higher federal reimbursements for COVID-related cases, potentially incentivizing the over-attribution of the virus as a cause of death.
